News
On October 5, 2022, the Cabinet of Ministers of the Republic of Uzbekistan (hereinafter – “Uzbekistan”) adopted the Resolution “On the Approval of Certain Regulatory Legal Acts in the Field of Personal Data Processing” No. 570 (hereinafter – the “Resolution”). The Resolution will come into force on January 7, 2023. Please see below some of the key, from our standpoint, changes provided by the Resolution.
On October 27, 2022, the Resolution of the President of the Republic of Uzbekistan (hereinafter – “Uzbekistan”) “On Additional Measures to Provide the Population with Quality Medicines and Medical Devices” No. PP-411 dated October 26, 2022 (hereinafter – the “Resolution”) came into force. Please see below some of the key, from our standpoint, changes provided by the Resolution.
- What is digital labelling of medicines?
Digital labelling of a medicine means assigning each medicinal package a unique Data Matrix code, which is a two-dimensional matrix barcode in black and white applied in the form of a square, intended for encoding information about the product suitable for machine reading.
On September 29, 2022 the Law of the Republic of Uzbekistan (hereinafter – “Uzbekistan”) “On Electronic Commerce” No. LRU-792, (hereinafter – the “Law”) was adopted. The Law will enter into force on December 30, 2022. Please see below our summary of some of the key changes provided by the Law.
Amendments have been introduced to the Rules on medicines and medical devices’ advertising
The amendments to the Rules on medicines and medical devices’ advertising[1] (the “Rules”) entered into force on September 23, 2022[2].
The amendments are related to the following:
- The certificate of compliance of the advertisement with the healthcare legislation of the Republic of Kazakhstan (the “RK”) is from now on to be issued by the “National Scientific Center for Health Development named after Salidat Kairbekova”, the state agency under the Ministry of Health of the RK[3];
- A subparagraph stipulating that the logo, trade and (or) international non-proprietary name depicted on the products distributed among medical and pharmaceutical workers (pens, notebooks, bags, medical gowns, calendars, business card holders, flash drives, etc.) shall not be considered as medicines and medical devices’ advertising was omitted from the Rules[4].
On June 7, 2022, the Law of the Republic of Uzbekistan (hereinafter – “Uzbekistan”) “On Advertising” No. LRU-776 (hereinafter – the “Law”) was adopted. The Law will enter into force on September 9, 2022. Please see below some of the key, in our opinion, changes provided by the Law.
General Provisions
The Law provides for an expanded definition of the advertising term. After adoption of the Law advertising is the special information the content of which is addressed to users within Uzbekistan and distributed through any advertising means, not only for the purpose of direct or indirect profit (income), but also to draw attention to the advertising object, to generate or maintain interest in this object, as well as to promote it on the market.
Resolution of the Cabinet of Ministers of the Republic of Uzbekistan “On Adoption of the Regulation “On the Procedure for Issuing an Electronic Digital Signatures through Consular Offices of the Republic of Uzbekistan Abroad” No. 413 dated 29.07.2022 (hereinafter referred to as the “Resolution”) establishes the long-awaited procedure for obtaining an electronic digital signature (hereinafter referred to as the “E-signature”) through the consular departments of diplomatic missions and consulates of the Republic of Uzbekistan (hereinafter referred to as "Uzbekistan") abroad (hereinafter referred to as the “Consulate”).
On July 9, 2022 the amendments to Order of the acting Minister of Health of the Republic of Kazakhstan dated June 23, 2022 No. ҚР ДСМ-56 “On the amendments and additions to Order of the Minister of Health of the Republic of Kazakhstan dated December 11, 2020 No. ҚР ДСМ-247/2020 “On approval of the Rules for Regulation, Formation of the Ceiling Prices and Markups for Medicines, as well as Medical Devices within the Guaranteed Volume of Free Medical Care and/or in the system of Obligatory Social Health Insurance” (“Order No. 56”) took effect[1].
According to the Decree of the President of the Republic of Uzbekistan (hereinafter referred to as “Uzbekistan”) “On Additional Measures for the Accelerated Development of the Pharmaceutical Industry of the Republic in 2022–2026” No. UP-55 dated 21.01.2022 (hereinafter referred to as the “Decree No. UP-55”), from 01.04.2022 it is planned to introduce a mechanism for guaranteed procurement of pharmaceutical products subject to localization (hereinafter referred to as the “Procurement”) by concluding a contract for a 3 years period. The Procurement will be carried out at the expense of the State budget, which will be allocated for the procurement of pharmaceutical products.